Atai Life Sciences B.V. (ATAI)
Atai Life Sciences (ATAI) is gaining traction in the psychedelic sector, with recent positive analyst ratings and a Buy recommendation, despite a recent stock offering dip. The company's involvement in promising biotech catalysts and positive portfolio performance is driving investor interest.
About Atai Life Sciences B.V.
Atai Life Sciences B.V. is a biotechnology company focused on developing novel treatments for psychiatric conditions.
Atai Life Sciences B.V. uses the ticker $ATAI for trading. Listed in the Stocks category within the Bitcoin Treasuries sectors.
Insights
- Atai Life Sciences B.V. (ATAI) social dominance is up 217.74% from the previous week.
- Atai Life Sciences B.V. (ATAI) Galaxy Score™ is up 46% from the previous [--] months.
- Atai Life Sciences B.V. (ATAI) sentiment is up 28.21% from the previous week.
- Atai Life Sciences B.V. (ATAI) engagements is up 36.68% from the previous week.
- Atai Life Sciences B.V. (ATAI) posts created is up 161.11% from the previous week.
Price: $3.80
Price 24-Hour Time-Series Raw Data
The stock price is currently experiencing a short-term dip due to a recent stock offering, but positive sentiment from FDA designation, a successful raise, and strong portfolio performance, coupled with analyst initiation of coverage with a Buy rating and a $16 target, suggests a potential rebound.
24-Hour: 0.26% 7-Day: -2.82% 30-Day: -1.56%
1-Year High: $6.50 on 2025-10-17
1-Year Low: $1.20 on 2025-04-08
AltRank: [---]
AltRank 24-Hour Time-Series Raw Data
Atai Life Sciences B.V. (ATAI) is currently AltRank #854 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [---] [----]
[--] Month: [---] +170
[--] Months: [---] +576
1-Year High: [-----] on 2026-02-03
1-Year Low: [--] on 2025-07-19
Galaxy Score: [--]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [--] +11
[--] Month: [--] +15
[--] Months: [--] [---]
[--] Year: [--] +32
1-Year High: [--] on 2025-07-18
1-Year Low: [--] on 2025-04-19
Engagements: [------] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [------]
[--] Week: [-------] +37%
[--] Month: [-------] -17%
[--] Months: [---------] -33%
[--] Year: [----------] +51%
1-Year High: [-------] on 2025-06-02
1-Year Low: [---] on 2025-04-19
Engagements by network (24h): X: [------] News: [--] YouTube: [--] TikTok: [--] Reddit: [--]
Mentions: [---] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] +3.50%
[--] Month: [---] +6.70%
[--] Months: [-----] -67%
[--] Year: [------] +224%
1-Year High: [-----] on 2025-07-06
1-Year Low: [--] on 2025-04-19
Mentions by network (24h): X: [---] News: [--] YouTube: [--] TikTok: [--] Reddit: [--]
Creators: [---] (24h)
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning Atai Life Sciences B.V. (ATAI) in the last [--] hours which is down 2.50% from [---] in the previous [--] hours
Daily Average: [---]
[--] Week: [---] -4.30%
[--] Month: [---] -2.90%
[--] Months: [-----] -82%
[--] Year: [------] +564%
1-Year High: [-----] on 2025-07-06
1-Year Low: [--] on 2025-04-28
The most influential creators that mention Atai Life Sciences B.V. in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BiopharmIQ | [--] | [------] | [--] | [-----] |
| @peter_mantas | [--] | [-----] | [--] | [-----] |
| @MultibaggerRsch | [--] | [-----] | [--] | [-----] |
| @mtracey | [--] | [---] | [--] | [-----] |
| @TopStockAlerts1 | [--] | [-------] | [--] | [---] |
| @mchilberg | [--] | [------] | [--] | [---] |
Sentiment: 75%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 75%
Daily Average: 84%
[--] Week: 100% +22%
[--] Month: 88% +1%
[--] Months: 88% -3%
[--] Year: 88% -2%
1-Year High: 100% on 2025-03-10
1-Year Low: 33% on 2025-03-31
Most Supportive Themes:
- Positive Portfolio Performance: (40%) Users are highlighting ATAI's positive performance in their investment portfolios, recommending it as a buy and celebrating gains.
- Analyst Ratings and Price Targets: (20%) Posts mention positive analyst ratings and price targets for ATAI, indicating confidence in its future performance.
- Biotech Catalyst Watchlists: (15%) Mentions of ATAI in biotech catalyst watchlists, particularly those with upcoming data readouts, generate positive sentiment.
Most Critical Themes:
- Recent Stock Offering Impact: (25%) A recent stock offering caused a price drop, leading to negative sentiment and concerns about dilution.
Social Dominance: 0.015%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.015%
Daily Average: 0.035%
[--] Week: 0.017% +0.012%
[--] Month: 0.036% +0.018%
[--] Months: 0.036% +0.0048%
[--] Year: 0.036% +0.0041%
1-Year High: 0.278% on 2025-07-06
1-Year Low: 0.0044% on 2025-04-19
Market Dominance: 0.00156%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00156%
Daily Average: 0%
1-Year High: 0.00269% on 2025-10-27
1-Year Low: 0.00039% on 2025-05-13
Market Cap: $1,383,847,634
Market Cap 24-Hour Time-Series Raw Data
Current Value: $1,383,847,634
Daily Average: $1,093,985,139
[--] Week: $1,402,008,364 -1%
[--] Month: $1,383,847,634 +4.70%
[--] Months: $1,383,847,634 +47%
1-Year High: $2,258,571,879 on 2025-10-27
1-Year Low: $278,469,277 on 2025-05-09
Top Atai Life Sciences B.V. Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"@MultibaggerRsch $HELP next one with data readout in Q1 - Phase [--] using DMT for GAD (General Anxiety Disorder) 🍄 Big hedge funds in this name and new CEO who sold his last company Shire Pharma for $62 billion to Takeda $HELP will be sold to Big Pharma $CMPS $ATAI $GHRS $XBI @Psymarketcapcom I agree. Which is your favorite stock @Psymarketcapcom I agree. Which is your favorite stock"
X Link @c2412345 2026-02-17T20:45Z [---] followers, [---] engagements
"$CMPS @COMPASSPathway $HELP @Helus_Pharma $GHRS @ghresearch_plc $ATAI @ataibeckley are LONG positions in the $PSIL AdvisorShares Psychedelics ETF. Learn more at https://hubs.li/Q043qnL80 https://hubs.li/Q043qnL80"
X Link @AdvisorShares 2026-02-17T19:00Z [----] followers, [---] engagements
"@ChartGuys time to do a YouTube recap with @PsychedVantage for what $CMPS data readout means for the psychedelics sector 🙏 $CMPS drug is competitive with $JNJ SPRAVATO (esketamine) $3B to $3.5B in annual sales by [--------] 🤑 $HELP DMT data in Q1 soon 🔮 $ATAI $DFTX $XBI $CMPS data reaction today is going to be the highest dollar volume day ever for the stock. $CMPS data reaction today is going to be the highest dollar volume day ever for the stock"
X Link @c2412345 2026-02-17T18:23Z [---] followers, [---] engagements
"Biotech Catalyst Watchlist - Q1 [----] (Stocks Under $5) Probability of approval score card is below $GOSS Phase [--] $TELO Pre-clinical $RCKT PDUFA $MGX Pre-clinical $SXTP Phase [--] $NAYA Phase 1/2a $ATAI Phase [--] $XLO Pre-clinical $ATAI Phase [--] $PYPD NDA $ACRS Phase 1a $NMRA Phase [--] $IMAB Phase 1b $OCGN Phase 2/3 $ANNX Phase [--] $BTAI NDA $BFRI Phase 2b $MBRX Phase 1b/2 $PALI Phase 1b $PMVP Phase [--] $MENS Phase [--] $INMB Phase [--] $GTBP Phase 1"
X Link @Biopharma_Watch 2026-02-17T18:10Z [----] followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing